ISSUE 1361
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
The FDA has approved an intravenous (IV) formulation of acetaminophen (Ofirmev – Cadence) for use in patients ≥2 years old for management of pain either as monotherapy (mild to moderate pain) or with an opioid (moderate to severe pain) and for reduction of fever.
FORMULATIONS — An IV formulation of propacetamol, a prodrug of acetaminophen, has been available in Europe for more than 20 years, but needs reconstitution and has been associated with pain on injection. An IV formulation of acetaminophen itself that does not require reconstitution and is less likely to cause pain on injection has been available in Europe since 2002.
IV NONOPIOIDS FOR PAIN — Ketorolac was the first nonsteroidal anti-inflammatory drug (NSAID) to become available in an injectable formulation in the US; it is marketed for short-term (up to 5 days) use. IV or intramuscular ketorolac is comparable
... more1. Drugs for pain. Treat Guidel Med Lett 2010; 8:25.
2. Intravenous ibuprofen (Caldolor). Med Lett Drugs Ther 2010; 52:3.
3. ST Duggan and LJ Scott. Intravenous paracetamol (acetaminophen). Drugs 2009; 69:101.
8. Pharmaceutical drug overdose. Treat Guidel Med Lett 2006; 4:61.
9. Addendum: warfarin-acetaminophen interaction. Med Lett Drugs Ther 2008; 50:45.
Would you like to read the rest of this article? Gain access below.
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Article code: 1361c
Electronic, downloadable article - $45
